Immunize.org supports evidence-based vaccination recommendations and schedules. Read more at About Us.

Ask the Experts: Storage & Handling: Vaccine-specific Questions

Results (30)

Both vaccines should be stored at refrigerator temperature and protected from light. Do not administer the vaccine if it has been frozen or exposed to freezing temperatures.

Last reviewed: June 7, 2023

Hib vaccine should be maintained at refrigerator temperature between 2°C and 8°C (36°F and 46°F). Manufacturer package inserts contain additional information and can be found at  www.immunize.org/official-guidance/fda/pkg-inserts/. For complete information on best practices and recommendations please refer to CDC’s Vaccine Storage and Handling Toolkit available at this website: www.cdc.gov/vaccines/hcp/storage-handling/index.html.

Last reviewed: January 21, 2025

No. You should only use the (0.4% NaCl) diluent provided with the Dengvaxia vaccine vial. Contact your immunization program or the manufacturer for additional guidance.

Last reviewed: January 17, 2025

Store both the vaccine antigen and the diluent in a refrigerator at 36°F–46°F (2°C–8°C). Do not freeze. Protect from light. After reconstitution, administer Dengvaxia immediately or store refrigerated at 36°F–46°F (2°C–8°C) and use within 30 minutes.

Do not use the vaccine if it has been reconstituted for over 30 minutes. Contact your public health immunization program or the manufacturer for advice if vaccination occurs using vaccine that has been reconstituted more than 30 minutes, or in the event of other storage or handling errors.

The manufacturer package insert contains additional information and can be found at www.fda.gov/media/124379/download.

For complete information on vaccine storage and handling best practices and recommendations, please refer to CDC’s Vaccine Storage and Handling Toolkit at www.cdc.gov/vaccines/hcp/admin/storage/toolkit/storage-handling-toolkit.pdf.

Last reviewed: January 17, 2025

HPV vaccine should be stored at refrigerator temperature between 2°C and 8°C (36°F and 46°F). The vaccine must not be frozen and must not be used if it has been frozen. Protect the vaccine from light. Administer as soon as possible after being removed from refrigeration. The manufacturer package insert contains additional information and can be found at https://www.immunize.org/official-guidance/fda/pkg-inserts/. For complete information on vaccine storage and handling best practices and recommendations, please refer to CDC’s Vaccine Storage and Handling Toolkit at www.cdc.gov/vaccines/hcp/admin/storage/toolkit/storage-handling-toolkit.pdf.

Last reviewed: March 2, 2024

Store any brand of MenACWY, MenB, or MenABCWY vaccine at refrigerator temperature, between 2° and 8°C (between 36° and 46°F). These vaccines must not be frozen. Vaccine that has been frozen or exposed to freezing temperature should not be used. Do not use after the expiration date.

Last reviewed: November 15, 2024

Arexvy (GSK) is stored in the refrigerator and is available in two presentations: a vial of lyophilized antigen (powder) paired with either a vial or a prefilled syringe of adjuvant suspension (liquid). Reconstitute only with the supplied adjuvant component. Both the liquid and the powder should be stored refrigerated between 2°C and 8°C (36°F and 46°F) in the original package in order to protect the components from light. Do not freeze. Discard if either component has been frozen.

After reconstitution, administer immediately or store in the refrigerator between 2°C and 8°C (36°F to 46°F) or at room temperature (defined for this vaccine as up to 25°C [77°F]) for up to 4 hours before use. Discard reconstituted vaccine if not used within 4 hours. See the current package insert: https://www.fda.gov/media/167805/download.

Last reviewed: November 8, 2026

The mRNA RSV vaccine (mResvia, Moderna) is supplied as a manufacturer-filled syringe (MFS) that contains a frozen suspension that must be thawed before administration either in the refrigerator or at room temperature. Vaccine should not be refrozen once thawed. Do not shake any mRNA vaccine because shaking can damage the potency of the vaccine by breaking up the small bubbles of fat (lipid) that contain the mRNA.

  • Freezer storage: The frozen vaccine in the plastic MFS can be stored in the freezer between -40°C to -15°C (-40°F to 5°F) until the expiration date printed on its packaging.
  • Refrigerator storage: The thawed plastic MFS may be stored refrigerated between 2°C to 8°C (36°F to 46°F) for up to 90 days before being used, or until its labeled expiration date, whichever comes first. If stored in the refrigerator, place a label on the vaccine indicating when it was placed in the refrigerator and its ‘use by date’, which is 90 days later. Discard an MFS that has been in the refrigerator beyond its 90-day use-by date.
  • Room temperature storage: The thawed plastic MFS may be stored between 8°C to 25°C (46°F to 77°F) for a total of 24 hours after removal from refrigerated conditions. Discard the MFS if not used within this time. Do not return an MFS to the refrigerator after it has been thawed at room temperature.
  • Refer to the mResvia package insert for specific instructions and additional details on storage and thawing: fda.gov/media/179005/download. Follow the current label for the presentation; the label specifies the need to protect the vaccine from direct sunlight and ultraviolet light. Never use beyond the expiration date.
Last reviewed: November 8, 2026

Nirsevimab (Beyfortus, Sanofi) comes in two single-dose manufacturer-filled syringe (MFS) formulations: 50-mg and 100-mg. Nirsevimab should be stored in the refrigerator between 36°F to 46°F (2°C to 8°C). It may be kept at room temperature 68°F to 77°F (20°C to 25°C) for a maximum of 8 hours. After removal from the refrigerator, nirsevimab must be used within 8 hours or discarded. Store nirsevimab in the original carton to protect it from light until time of use. Do not freeze. Do not shake. Do not expose to heat.

Last reviewed: November 8, 2026

Clesrovimab (Enflonsia, Merck) comes in a manufacturer-filled syringe (MFS) as a 105-mg, 0.7 mL dose. The MFS should be refrigerated at 36°F to 46°F (2°C to 8°C) in the original carton to protect from light until time of use.

Clesrovimab may be kept at room temperature between 68°F to 77°F (20°C to 25°C) for a maximum of 48 hours. After removal from the refrigerator, it must be used within 48 hours or discarded.

Clesrovimab should not be used if frozen. The MFS should not be shaken.

Last reviewed: November 8, 2026

Live varicella-containing vaccines (varicella, MMRV) must be stored in a freezer at a temperature between -50°C and -15°C (between -58°F and +5°F) until reconstitution and administration. These vaccines can deteriorate rapidly after they are removed from the freezer. A separate stand-alone freezer or a combination refrigerator-freezer purpose-built for vaccine storage (sometimes called “pharmaceutical grade”) should be used to store frozen vaccines that require storage temperatures between -50°C and -15°C (between -58°F and +5°F). A stand-alone storage unit that is frost-free or has an automatic defrost cycle is preferred. Frozen vaccines should not be stored in the freezer compartment of a household-type combination unit because household freezers in combination units cannot reliably maintain proper storage temperatures for frozen vaccines. This applies to both temporary and long-term storage of frozen vaccines. The diluents should be kept separately in the refrigerator or at room temperature. Live varicella-containing vaccines must be administered within 30 minutes of reconstitution.

Last reviewed: August 12, 2026

No. Seasonal influenza vaccines are reformulated each year; for this reason, all unused seasonal influenza vaccines expire and should be discarded no later than the end of June each season. RSV products (vaccines and preventive antibody) do not change each season and products in your storage unit now may not expire until sometime during or after the next season.

Properly store and clearly label unexpired products remaining in your storage unit during periods when they are not in use and train staff on the timing of these products, especially for vaccination during pregnancy and use of RSV preventive antibody products. Consider storage and labeling that minimizes the risk of mishandling or administration outside the times when the product is recommended to be used.

Last reviewed: November 8, 2026


2:41

View All Video Questions

Last reviewed: December 6, 2024

Vaccine may lose potency rapidly if not stored according to the manufacturer’s instructions. However, it may still be permissible to use vaccine that has not been properly stored. Put the affected vaccine vials into the freezer after you have marked them so they are not used or confused with the unaffected vials, then call the manufacturer at 1-800-9-VARIVAX (1-800-982-7482) for further guidance about whether the vaccine is still usable. Unreconstituted varicella vaccine may be stored in the refrigerator for up to 72 hours before use. If refrigerated varicella vaccine is not used within 72 hours, it should be discarded.

If you have inadvertently left your vaccine at room temperature instead of in the freezer or have experienced a power failure, label the affected vaccine to keep it unused and separated from unaffected vaccine and return it to recommended storage conditions in a freezer promptly, then contact the manufacturer for further guidance. Do not administer the vaccine until you have consulted with Merck.

Last reviewed: August 12, 2026

The vaccine manufacturer does not recommend routinely transporting varicella-containing vaccines (varicella, MMRV). If these vaccines must be transported (for example during an emergency), CDC recommends use of a portable vaccine freezer unit or qualified container and packout that maintains temperatures between -50°C and -15°C (- 8°F and +5°F). Do not use dry ice, even for temporary storage. Dry ice might expose the vaccines to temperatures colder than -50°C (-58°F), resulting in compromise of the vial stopper material.

Follow these steps for transporting frozen vaccines:

  • Place a temperature monitoring device (preferably with a buffered probe) in the container as close as possible to the vaccines.
  • Immediately upon arrival at the destination, unpack the vaccines and place them in a freezer at a temperature range between -50°C and -15°C (-58°F and +5°F). Any stand-alone freezer or freezer purpose built for vaccine storage that maintains these temperatures is acceptable.
  • Record the time vaccines are removed from the storage unit and placed in the transport container, the temperature during transport, and the time at the end of transport when vaccines are placed in a stable storage unit.

If necessary, varicella-containing vaccines may be transported or stored at refrigerator temperature between 2°C and 8°C (between 36°F and 46°F) for up to 72 continuous hours prior to reconstitution. To do so, follow the steps above using a portable vaccine refrigerator unit or a qualified container and packout designed to maintain vaccine storage temperatures between 2°C and 8°C (between 36°F and 46°F).

Transport of varicella-containing vaccine at temperatures other than the recommended range between -50°C and -15°C (-58°F and +5°F) is considered a temperature excursion, so contact Merck at (800) 982-7482 for further guidance. Do not discard vaccines without contacting the manufacturer and/or your immunization program for guidance.

For additional guidance, see the CDC Vaccine Storage and Handling Toolkit at www.cdc.gov/vaccines/hcp/storage-handling/index.html#toc.

Last reviewed: August 12, 2026

There are two presentations of Shingrix: a manufacturer-filled syringe (MFS) and a presentation that requires reconstitution with a lyophilized antigen vial and an adjuvant suspension vial. Both presentations, including the lyophilized antigen vial and the adjuvant suspension diluent, must be stored at refrigerator temperature, between 2° and 8°C (between 36° and 46°F). Protect from light. Do not freeze. Vaccine or adjuvant solution that has been frozen must be discarded. If vaccine that was frozen was administered, the dose does not count and should be repeated. The repeat dose should be administered 4 weeks after the frozen dose. When using the presentation that requires reconstitution, after reconstitution, administer Shingrix immediately or store refrigerated between 2° and 8°C (between 36° and 46°F) and use within 6 hours. Discard reconstituted vaccine if not used within 6 hours.

Last reviewed: August 25, 2025

Yes. According to the manufacturer, unreconstituted varicella vaccine may be stored at refrigerator temperature (2°C to 8°C, 36°F to 46°F) for up to 72 continuous hours prior to reconstitution. Vaccine stored at 2°C to 8°C that is not used within 72 hours of removal from -15°C (+5°F) storage should be discarded. See www.merck.com/product/usa/pi_circulars/v/varivax/varivax_pi.pdf.

Last reviewed: August 12, 2026

Shingrix is stored at refrigerator temperature. Transport of refrigerated vaccines is described in detail in the CDC Storage and Handling Toolkit, available at www.cdc.gov/vaccines/hcp/admin/storage/toolkit/storage-handling-toolkit.pdf, beginning on page 23. Providers should also review the vaccine package inserts for the specific vaccines being transported.

Last reviewed: August 25, 2025

All hepatitis A-containing vaccine should be stored at refrigerator temperature at 2°C to 8°C (36°F to 46°F). The vaccine must not be frozen. Any vaccine exposed to freezing temperature should not be used. Do not use these or any other vaccines after the expiration date shown on the packaging. Any vaccine administered after its expiration date is not valid and should be repeated.

Last reviewed: June 25, 2023

The amount of time in which a dose of vaccine must be used after reconstitution varies by vaccine and is usually outlined in the vaccine’s package insert. MMR must be used within 8 hours of reconstitution. MMRV must be used within 30 minutes; other vaccines must be used “immediately,” which is not a clearly defined term but may be considered to be within 30 minutes. Immunize.org has a staff education piece that outlines the time allowed between reconstitution and use, as stated in the package inserts for a number of vaccines. This handout can be found at the following link: www.immunize.org/wp-content/uploads/catg.d/p3040.pdf.

Last reviewed: August 10, 2026

MMRII (Merck) brand of MMR vaccine may be stored either in the refrigerator at 2°C to 8°C (36°F to 46°F) or in the freezer at -50°C to -15°C (-58°F to +5°F). Prescribing information for the Priorix (GSK) brand of MMR vaccine states that it should be stored refrigerated (at 2°C to 8°C), but not in the freezer. For both brands, the diluent should not be frozen and can be stored in the refrigerator or at room temperature.

If the MMR is combined with varicella vaccine as MMRV (ProQuad, Merck), it must be stored in the freezer at -50°C to -15°C (-58°F to +5°F).

Last reviewed: August 10, 2026

Unfortunately, serious errors in vaccine storage and handling like this occur too often. If you suspect that vaccine has been mishandled, you should take the following steps: label the affected vaccine package clearly so it will not be used before knowing whether it is still usable, return the vaccine to recommended storage conditions, and then contact the manufacturer or state/local health department for guidance on whether it is still usable or should be wasted. This is particularly important for live virus vaccines like MMR and varicella.

Last reviewed: August 10, 2026

The guidance for handling after reconstitution is the same for both brands of MMR vaccine (MMRII and Priorix). It is preferable to administer MMR immediately after reconstitution. If not used immediately, the reconstituted vaccine should be store refrigerated (2°C to 8°C [36°F to 46°F]) until use. If reconstituted MMR is not used within 8 hours, it must be discarded.

Last reviewed: August 10, 2026

Only the diluent supplied with the MMR vaccine should be used to reconstitute any vaccine. A vaccine reconstituted with the incorrect diluent should not be used. If administered, the dose should be repeated.

Last reviewed: August 10, 2026

All pneumococcal vaccines should be refrigerated at temperatures between 2°C (36°F) and 8°C (46°F). Do not freeze these vaccines. Vaccine exposed to freezing temperature should not be administered. For details of vaccine storage and handling, see the CDC Vaccine Storage and Handling Toolkit: www.cdc.gov/vaccines/hcp/downloads/storage-handling-toolkit.pdf.

Last reviewed: November 13, 2024

Each of these products must be stored at 2° to 8°C (36° to 46°F). They should not be frozen or exposed to freezing temperatures.

Last reviewed: March 31, 2022

All 2026–27 influenza vaccines, including inactivated, recombinant, live attenuated, and mRNA vaccines, should be stored refrigerated at 2° through 8°C (36° through 46°F). Do not freeze influenza vaccine, and do not use vaccine that has been frozen. Follow each manufacturer’s package insert for product-specific handling and storage information.

Last reviewed: October 11, 2026

For the 2026–2027 season, Comirnaty manufacturer-filled syringes (MFS), mNexspike MFS, and Nuvaxovid MFS all should be stored exclusively in the refrigerator at standard vaccine storage temperatures (between 2°C and 8°C [36°F and 46°F]) until the printed expiration date.

Spikevax MFS, if received frozen and never thawed, may be stored at ordinary vaccine freezer storage temperatures (between -50°C and -15°C [-58°F and 5°F]) until the printed expiration date. Once thawed, it may be stored at standard vaccine refrigerator temperatures (above) for up to 60 days or until the expiration date (whichever comes first).

Comirnaty single dose vials (SDV) for ages 6 months through 11 years, if received frozen and never thawed, may be maintained until the printed expiration date in an ultracold freezer between -90°C and -60°C (-130°F and -76°F). Once thawed, it may be stored at standard vaccine refrigerator temperatures (above) for up to 10 weeks, or until the expiration date, whichever comes first.

For further details, refer to the specific vaccine’s package insert. Immunize.org has assembled links to key COVID-19 vaccine resources, including package inserts, in the Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools: www.immunize.org/catg.d/p3130.pdf.

Last reviewed: October 18, 2026

Although routine transportation of vaccines to different facilities is not generally recommended, there are times when this is necessary. CDC recommends transporting COVID-19 vaccine in unopened vials or manufacturer-filled syringes (MFS) and always with a continuous temperature monitoring device to ensure adherence to authorized storage times and temperatures. See the product package insert for details on permissible conditions for transport.

Last reviewed: October 18, 2026

All hepatitis B-containing vaccines should be stored at refrigerator temperature at 2°C to 8°C (36°F to 46°F). The vaccines must not be frozen. Any vaccine exposed to freezing temperature should not be used. Do not use these or any other vaccines after the expiration date shown on the packaging. Any vaccine administered after its expiration date should be repeated.

Last reviewed: January 17, 2025

This page was updated on .